* Prosomnus Inc OSA.OQ OSA.O is expected to report
results on
May 9.
* The Shanghai-based company is expected to report revenue
of
$5.75 million, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prosomnus Inc is
for a
loss of 39 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "Buy".
* Wall Street's median 12-month price target for Prosomnus
Inc is
$9.5, above its last closing price of $5.03.
This summary was machine generated May 6 at 02:09 GMT. All
figures in US dollars unless otherwise stated